I know right? More likely Organovo will move along (kinda what I hope) and slowly grow the company with 3d bioprinting. The stocks will follow eventually, at which point it'll be expensive to buyout, again. If it grows into the true potential of replacement organs, people who did buy at under $2 will feel like genius. If it gets bought for something like $2 or $3 a share I'll be surprised, and a little bummed. A share swap would be ok I guess at that valuation, since whoever buys them will reap the huge rewards and in that case I still stay for the ride.
Maybe someone out there with a MA budget is just about to jump on that fact sooner rather than later, when it's gets more expensive. It's a well run company with huge upside potential so, yeah buyout has been something to think about. Just makes ONVO one of those stocks that can vault instantly from outta nowhere.
Just sayin...
News 
Market Data 
Discover 
